Small molecule inhibitors to reprogram the tumour environment and improve immunotherapy

  • Ganss, Ruth (Chief Investigator)
  • Hammerling, Gunter (Investigator 02)

Project Details

StatusFinished
Effective start/end date1/01/1831/12/21

Funding

  • National Health & Medical Research Council NHMRC: A$295,195.00
  • National Health & Medical Research Council NHMRC: A$254,130.00
  • National Health & Medical Research Council NHMRC: A$235,195.00